Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
doi: 10.3389/fmicb.2017.01725 535 BlaakEECanforaEETheisSFrostGGroenAKMithieuxGet al
As part of this process, we may approve, restrict, or deny account access, or place limitations on account activity, at our discretion
If international shipping becomes available, well announce it on our website
We may receive compensation via a service called Linkby when you click on the links in this article
J., Veierod, M
However, Hims faced swift backlash from Novo Nordisk , which called the move an unlawful attempt to "mass-market an unapproved, inauthentic and untested knock-off semaglutide pill." The Danish pharma giant continued: "The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety." "Novo Nordisk will take legal and regulatory action to protect patients, our intellectual property and the integrity of the US gold-standard drug approval framework." "This is another example of Hims & Hers' historic behaviour of duping the American public with knock-off GLP-1 products and the FDA has previously warned them about their deceptive advertising of GLP-1 knock-offs." Hims' compounded drug is not FDA-approved and has not undergone clinical trials to demonstrate efficacy
US$ 21.06
US$ 24.06
US$ 21.05
US$ 26.50
